Naproxen Sodium (nsaid) Tablet
FDA Label NDC 53746-191

15 label sections · Submitted to the FDA by Amneal Pharmaceuticals Of New York Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Amneal Pharmaceuticals Of New York Llc for the product Naproxen Sodium (nsaid) (NDC 53746-191). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, purpose, indication and usage, warnings, do not use, ask doctor/pharmacist, when using, stop use, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.